| Issue Date | Title | Author(s) | Type | Мp-cat. |
| 2022 | Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric Surgery | Porat, Daniel; Dukhno, Oleg; Vainer, Ella; Cvijić, Sandra   ; Dahan, Arik | Article | |
| 2024 | Erectile Dysfunction Therapy of Bariatric Patients: Tadalafil Biopharmaceutics and Pharmacokinetics Before vs. After Gastric Sleeve/Bypass | Porat, Daniel; Dukhno, Oleg; Cvijić, Sandra ; Dahan, Arik | Article | |
| 2025 | Physiologically Based Pharmacokinetic Modeling for Predicting Drug Levels After Bariatric Surgery: Vardenafil Exposure Before vs. After Gastric Sleeve/Bypass | Porat, Daniel; Dukhno, Oleg; Cvijić, Sandra ; Dahan, Arik | Article | |
| 2023 | Selective COX-2 inhibitors after bariatric surgery: Celecoxib, etoricoxib and etodolac post-bariatric solubility/dissolution and pharmacokinetics | Porat, Daniel; Dukhno, Oleg; Partook-Maccabi, Mazal; Vainer, Ella; Cvijić, Sandra ; Dahan, Arik | Article | |
| 2023 | The Complexity of Bariatric Patient’s Pharmacotherapy: Sildenafil Biopharmaceutics and Pharmacokinetics before vs. after Gastric Sleeve/Bypass | Porat, Daniel; Dukhno, Oleg; Cvijić, Sandra ; Dahan, Arik | Article | |
| 2022 | The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil | Marković, Milica; Zur, Moran; Garsiani, Sapir; Porat, Daniel; Cvijić, Sandra ; Amidon, Gordon L.; Dahan, Arik | Article | |